GSK3368715
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3368715, covering 2022-05-20 to 2022-05-20. Get the full timeline:
Most recent: Clinical Trial Update: First Time in Humans (FTIH) Study of GSK3368715 in Participants With Solid Tumors and Diffuse Large B-cell Lymphoma (DLBCL) [Phase 1]